Geneva — A pivotal moment in the fight to end AIDS — ensuring lifesaving innovation reaches those who need it most, wherever they live The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) today announced it has signed an access agreement with Gilead Sciences to procure lenacapavir, a long-acting injectable for HIV…
HIV/Aids breakthrough not a ‘cure’, popular social media posts misrepresent the facts IN SHORT: While promising, a recent breakthrough in HIV research is not a “cure” or a “vaccine”, as several posts claim on social media. The scientists involved say it could be many years before the technology is used as a cure. Users on…
Justin Mackenzie, Managing Director, VO Connect. (Image: Supplied) South Africa’s digital economy is accelerating fast. With a projected 92% increase in national data centre capacity by 2030, rising from 501.1MW to 962.4MW, according to Africa Data Centres, businesses across sectors are demanding faster, more reliable internet connections than ever before. However, there’s a bottleneck that…
Iqraam Rayners insisted the collective effort mattered more than his match-deciding strike after guiding Mamelodi Sundowns to a storm-delayed 1-0 victory over Ulsan HD in their FIFA Club World Cup Group F opener. The 29-year-old forward, whose neat 36-minute finish ultimately separated the sides in Orlando on Tuesday night, was named Man of the Match…
In a ground-breaking first for South Africa and the African continent, local patients are participating in a pioneering international gene-editing clinical trial that may revolutionise treatment for hereditary angioedema (HAE), a rare and potentially fatal genetic disorder. The clinical trial, now under way at the University of Cape Town’s (UCT) Lung Institute, uses CRISPR-Cas9 gene-editing…
